Prevalence of Osteosarcopenic Obesity in Older Adults

Obesity Clinical Trial

Official title:

Prevalence of Osteosarcopenic Obesity in Older Community-dwelling Adults in Turkey

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04288401
• Other study ID #: IstanbulMU3
• Status: Completed
• Start date: February 25, 2020
• Est. completion date: April 1, 2020

Study information

• Verified date: May 2020
• Source: Istanbul Medeniyet University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Osteosarcopenic Obesity (OSO) is a syndrome characterized by the loss of bone and muscle in addition to increase in the fat tissue as a result of aging process. It is the latest point of impairment in the bone,muscle and adipose tissue in older adults. OSO, as the name suggests, is the combination of three syndrome frequently encountered in the elderly: osteopenia/osteoporosis, sarcopenia and obesity. The aims of study are to determine the prevalence of OSO syndrome in community-dwelling adults of Turkey and determine the possible factors regarding risk of falling in this population

Recruitment information / eligibility

• Status: Completed
• Enrollment: 460
• Est. completion date: April 1, 2020
• Est. primary completion date: March 31, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 65 Years and older

Eligibility

Inclusion Criteria:

• Age of 65 or over

• Being had been examined for all the primary outcome measures (i.e. the results of primary outcomes must be in the patient's file)

Exclusion Criteria:

• Severe cognitive dysfunction

• not being able to walk independently for 4 m

Related Conditions & MeSH terms

• Bone Diseases, Metabolic
• Obesity
• Osteopenia
• Osteoporosis
• Sarcopenia

Locations

Country	Name	City	State
Turkey	Goztepe Training and Research Hospital	Istanbul

Sponsors (2)

Lead Sponsor	Collaborator
Istanbul Medeniyet University	Goztepe Training and Research Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	T score	T scores of spine and femur neck examined with Dual X-Ray Absorptiometry. A T score<-2,5 will be classified as osteoporosis while a T score between -1 and -2,5 will be counted as osteopenia	1 hour
Primary	Muscle Strength	Measured by hand held dynamometer. The cut-off scores for man and woman are 27 kg and 16 kg, respectively	5 minutes
Primary	Muscle Mass	Measured by bioimpedance analysis using Tanita TBF300. The cut-off scores for man and woman are 9,2 kg/m2 and 7,4 kg/m2, respectively	2 minutes
Primary	Muscle Performance	Tested by 4 meter walk test. If the gait speed is lower than 0,8 m/s, the test is positive.	3 minutes
Primary	Obesity	The fat percentage and the Body Mass Index measured by bioimpedance analysis using Tanita TBF300 is recorded. For BMI, 30 kg/m2 and over is classified as obesity whereas fat percentage of %35 and %28 (woman and man, respectively) and over was classified as obese.	2 minutes
Secondary	Comorbidity	Using Charlson Comorbidity Index	3 minutes
Secondary	History of falls	A patient's self stated history of falls will be considered as having a history of fall or not.	1 minutes